Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity

This publication has 53 references indexed in Scilit:

• Immunotherapy for Cancer
  Scientific American, 1996
• Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
  Science, 1994
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans
  Immunology Today, 1993
• Cancer vaccines
  Immunology Today, 1993
• Tumor Rejection After Direct Costimulation of CD8 ⁺ T Cells by B7-Transfected Melanoma Cells
  Science, 1993
• Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (αl-3)-galactose epitopes
  Clinical and Experimental Immunology, 1991
• Active immunotherapy in colorectal cancer
  Seminars in Surgical Oncology, 1989
• GLYCOBIOLOGY
  Annual Review of Biochemistry, 1988
• Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes.
  The Journal of Experimental Medicine, 1987